Applied UV Inc. (AUVI) shares declined 3.53% in after-hours on Friday, November 26, 2021, and closed the weekly trading at $4.92. However, in the regular trading session, AUVI’s stock gained 2.00%. AUVI shares have risen 1.19% over the last 12 months, and they have moved up 6.47% in the past week. Over the past three months, the stock has lost 22.73%, while over the past six months, it has plunged 38.18%.
Let’s see what are the latest news about the company?
AUVI Dividend Declaration
On November 23, 2021, the Board of Directors of Applied UV, Inc. (AUVI) authorized the cash dividend to holders of Applied UV’s 10.5% Series A Cumulative Perpetual Preferred Stock. Holders of the 10.5% Series A Cumulative Perpetual Preferred Stock shall receive a cash dividend equal to $0.21875 per share.
The preferred dividend will be paid on or about December 15, 2021, to respective holders of record at the close of business on December 3, 2021.
AUVI latest financial results
On November 16, 2021, Applied UV, Inc. (AUVI) announced its financial results for the third quarter of 2021.
Q3 2021 financial highlights
- AUVI reported total net sales of $3,551,564 in Q3 2021 compared to $1,560,633 in the third quarter of 2020.
- Cost of goods were $2,500,163 in Q3 2021 compared to $1,482,455 in Q3 2020.
- Total operating expenses were $ 2,683,025 in Q3 2021 compared to $968,972 in Q3 2020.
- It suffered a net loss of $1,080,805 or $0.14 loss per basic and diluted share in Q3 2021 compared to a net loss of $890,559 or $0.17 loss per basic and diluted share in Q3 2020.
AUVI participation in the recent conference
Applied UV, Inc. (AUVI) recently participated at Diamond Equity Research Emerging Growth Invitational Winter 2021 Spotlight Virtual Conference which was held on November 16, 2021.
AUVI SteriLumen Lumicide effectiveness
On November 5, 2021, Applied UV, Inc. (AUVI) announced that based on preliminary laboratory test results, its SteriLumen Lumicide™ Ribbon, which uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, kills the emerging multi-drug resistant fungus, Candida auris (C. auris). According to the CDC, C.auris can cause severe infections and spread easily between hospitalized patients and nursing home residents.
The results came from MRIGlobal, and ResInnova Laboratories, both of which are independent research organizations. The results confirmed that Applied UV’s Airocide and Sterilumen air purification and surface disinfection systems kill SARS-CoV-2 (the virus that causes COVID-19) and C. auris.
Well, there is no recent development to justify its mix performance on Friday. Let’s see how it performs after the weekend on Monday?